Patents by Inventor Angela SHE

Angela SHE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE
    Publication number: 20240043546
    Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
    Type: Application
    Filed: August 3, 2023
    Publication date: February 8, 2024
    Inventors: Vahe Bedian, Peter Harwin, Tomas Kiselak, Angela She, Jonathan Violin, Yang Zhao
  • COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE
    Publication number: 20230279122
    Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
    Type: Application
    Filed: January 5, 2023
    Publication date: September 7, 2023
    Inventors: Vahe Bedian, Peter Harwin, Tomas Kiselak, Angela She, Jonathan Violin, Yang Zhao
  • Compositions and methods for treatment of thyroid eye disease
    Patent number: 11548951
    Abstract: Antibodies and compositions against Insulin-Like Growth Factor-1 Receptor (IGF-1R) and uses thereof are provided herein and antibodies and pharmaceutical compositions that can be used in methods of treating or reducing the severity of thyroid eye disease (TED) in subjects in need thereof, including reducing proptosis and Clinical Activity Score (CAS) in said subjects, by inhibiting the activity of IGF-1R with such antibodies and compositions.
    Type: Grant
    Filed: August 29, 2022
    Date of Patent: January 10, 2023
    Assignee: VIRIDIAN THERAPEUTICS, INC.
    Inventors: Vahe Bedian, Peter Harwin, Tomas Kiselak, Angela She, Jonathan Violin, Yang Zhao
  • COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE
    Publication number: 20230002495
    Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
    Type: Application
    Filed: August 29, 2022
    Publication date: January 5, 2023
    Inventors: Vahe Bedian, Peter Harwin, Tomas Kiselak, Angela She, Jonathan Violin, Yang Zhao
  • COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE
    Publication number: 20220275096
    Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
    Type: Application
    Filed: April 20, 2022
    Publication date: September 1, 2022
    Inventors: Vahe Bedian, Peter Harwin, Tomas Kiselak, Angela She, Jonathan Violin, Yang Zhao
  • COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE
    Publication number: 20220267450
    Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
    Type: Application
    Filed: October 14, 2021
    Publication date: August 25, 2022
    Inventors: Vahe Bedian, Peter Harwin, Tomas Kiselak, Angela She, Jonathan Violin, Yang Zhao
  • COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE
    Publication number: 20220267451
    Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
    Type: Application
    Filed: October 14, 2021
    Publication date: August 25, 2022
    Inventors: Vahe Bedian, Peter Harwin, Tomas Kiselak, Angela She, Jonathan Violin, Yang Zhao
  • COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE
    Publication number: 20220235137
    Abstract: Antibodies and compositions against IGF-1R and uses thereof are provided herein.
    Type: Application
    Filed: October 14, 2021
    Publication date: July 28, 2022
    Inventors: Vahe Bedian, Peter Harwin, Tomas Kiselak, Angela She, Jonathan Violin, Yang Zhao
  • ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20220110960
    Abstract: Disclosed herein are acylated active agents and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.
    Type: Application
    Filed: December 21, 2021
    Publication date: April 14, 2022
    Inventors: Steven John TAYLOR, Mi-Jeong KIM, Kathleen NUDEL, Timothy F. BRIGGS, Koji YASUDA, Leonard BUCKBINDER, Bernard LANTER, Spencer Cory PECK, Cheri SNEDEKER, Angela SHE, Jessica ALEXANDER, Anna LIANG, Jenny LIU, Dinara GUNASEKERA, David Arthur BERRY, John Patrick CASEY, JR., Amir H. MOAREFI
  • DECARBOXYLASE INHIBITORS FOR TREATING PARKINSON'S DISEASE
    Publication number: 20220048849
    Abstract: Provided are inhibitors of pathogenic, bacterial metabolite production and conjugates of the inhibitors. Also provided are pharmaceutical compositions containing the inhibitors or conjugates and methods of using the same.
    Type: Application
    Filed: December 6, 2019
    Publication date: February 17, 2022
    Inventors: Devin Forest Reed DOUD, Timothy BRIGGS, Steven TAYLOR, Elijah BOGART, John PROUDFOOT, Dinara Shashanka GUNASEKERA, Spencer Cory PECK, Angela SHE, William MCELROY, Bernard LANTER, Michael RUTLIN
  • ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20210283157
    Abstract: Disclosed herein are acylated active agents and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.
    Type: Application
    Filed: May 13, 2021
    Publication date: September 16, 2021
    Inventors: Steven John TAYLOR, Mi-Jeong KIM, Kathleen NUDEL, Timothy F. BRIGGS, Koji YASUDA, Leonard BUCKBINDER, Bernard LANTER, Spencer Cory PECK, Cheri SNEDEKER, Angela SHE, Jessica ALEXANDER, Anna LIANG, Jenny LIU, Dinara GUNASEKERA, David Arthur BERRY, John Patrick CASEY, JR., Amir H. MOAREFI
  • Acylated active agents and methods of their use for the treatment of autoimmune disorders
    Patent number: 11058698
    Abstract: Disclosed herein are acylated active agents and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: July 13, 2021
    Assignee: Flagship Pioneering Innovations V, Inc.
    Inventors: Steven John Taylor, Mi-Jeong Kim, Kathleen Nudel, Timothy F. Briggs, Koji Yasuda, Leonard Buckbinder, Bernard Lanter, Spencer Cory Peck, Cheri Snedeker, Angela She, Jessica Alexander, Anna Liang, Jenny Liu, Dinara Gunasekera, David Arthur Berry, John Patrick Casey, Jr., Amir H. Moarefi
  • ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20200188418
    Abstract: Disclosed herein are acylated active agents and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.
    Type: Application
    Filed: February 27, 2020
    Publication date: June 18, 2020
    Inventors: Steven John TAYLOR, Mi-Jeong KIM, Kathleen NUDEL, Timothy F. BRIGGS, Koji YASUDA, Leonard BUCKBINDER, Bernard LANTER, Spencer Cory PECK, Cheri SNEDEKER, Angela SHE, Jessica ALEXANDER, Anna LIANG, Jenny LIU, Dinara GUNASEKERA, David Arthur BERRY, John Patrick CASEY, JR.